Global Liver Diseases Treatment Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 110
Inquire Before Buying

Liver Diseases Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Liver Diseases Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Chemotherapy Drugs

- Targeted Therapy

- Anti-Viral Drugs

- Immunoglobulins

- Corticosteroids

- Vaccines

- Anti-Rejection Drugs/Immunosuppressant

Segment by Application

- Cancer

- Hepatitis

- Cirrhosis

- Other

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Abbott Laboratories

- Bayer Schering

- Eli Lilly

- Merck

- Novartis

- Pfizer

- Roche

- Sanofi-Aventis

- Takeda Pharmaceutical

- Zydus Pharmaceuticals

- Glaxosmithkline

- Bristol-Myers Squibb

- General Electric

- Koninklijke Philips

- Siemens

- Canon Medical Systems Corp

- Hitachi

- Elekta

- Neusoft Corporation

- Samsung Healthcare

- BPL Medical Technologies

- Cura Healthcare

- Angion Biomedica

- Achillion Pharmaceuticals

- Gilead Sciences

- LG Life Sciences

- Verva Pharmaceuticals

- Shenzhen Kangtai Biological Products

- Raptor Pharmaceuticals

- ProMetic Life Sciences

- Phenex Pharmaceuticals

Global Liver Diseases Treatment Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Diseases Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Chemotherapy Drugs
1.2.3 Targeted Therapy
1.2.4 Anti-Viral Drugs
1.2.5 Immunoglobulins
1.2.6 Corticosteroids
1.2.7 Vaccines
1.2.8 Anti-Rejection Drugs/Immunosuppressant
1.3 Market by Application
1.3.1 Global Liver Diseases Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Hepatitis
1.3.4 Cirrhosis
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Liver Diseases Treatment Market Perspective (2017-2028)
2.2 Liver Diseases Treatment Growth Trends by Region
2.2.1 Liver Diseases Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Liver Diseases Treatment Historic Market Size by Region (2017-2022)
2.2.3 Liver Diseases Treatment Forecasted Market Size by Region (2023-2028)
2.3 Liver Diseases Treatment Market Dynamics
2.3.1 Liver Diseases Treatment Industry Trends
2.3.2 Liver Diseases Treatment Market Drivers
2.3.3 Liver Diseases Treatment Market Challenges
2.3.4 Liver Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liver Diseases Treatment Players by Revenue
3.1.1 Global Top Liver Diseases Treatment Players by Revenue (2017-2022)
3.1.2 Global Liver Diseases Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Liver Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liver Diseases Treatment Revenue
3.4 Global Liver Diseases Treatment Market Concentration Ratio
3.4.1 Global Liver Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Diseases Treatment Revenue in 2021
3.5 Liver Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Liver Diseases Treatment Product Solution and Service
3.7 Date of Enter into Liver Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liver Diseases Treatment Breakdown Data by Type
4.1 Global Liver Diseases Treatment Historic Market Size by Type (2017-2022)
4.2 Global Liver Diseases Treatment Forecasted Market Size by Type (2023-2028)
5 Liver Diseases Treatment Breakdown Data by Application
5.1 Global Liver Diseases Treatment Historic Market Size by Application (2017-2022)
5.2 Global Liver Diseases Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Liver Diseases Treatment Market Size (2017-2028)
6.2 North America Liver Diseases Treatment Market Size by Country (2017-2022)
6.3 North America Liver Diseases Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Liver Diseases Treatment Market Size (2017-2028)
7.2 Europe Liver Diseases Treatment Market Size by Country (2017-2022)
7.3 Europe Liver Diseases Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liver Diseases Treatment Market Size (2017-2028)
8.2 Asia-Pacific Liver Diseases Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Liver Diseases Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Liver Diseases Treatment Market Size (2017-2028)
9.2 Latin America Liver Diseases Treatment Market Size by Country (2017-2022)
9.3 Latin America Liver Diseases Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liver Diseases Treatment Market Size (2017-2028)
10.2 Middle East & Africa Liver Diseases Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Liver Diseases Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Liver Diseases Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Liver Diseases Treatment Business (2017-2022)
11.1.5 Abbott Laboratories Recent Development
11.2 Bayer Schering
11.2.1 Bayer Schering Company Detail
11.2.2 Bayer Schering Business Overview
11.2.3 Bayer Schering Liver Diseases Treatment Introduction
11.2.4 Bayer Schering Revenue in Liver Diseases Treatment Business (2017-2022)
11.2.5 Bayer Schering Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Liver Diseases Treatment Introduction
11.3.4 Eli Lilly Revenue in Liver Diseases Treatment Business (2017-2022)
11.3.5 Eli Lilly Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Liver Diseases Treatment Introduction
11.4.4 Merck Revenue in Liver Diseases Treatment Business (2017-2022)
11.4.5 Merck Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Liver Diseases Treatment Introduction
11.5.4 Novartis Revenue in Liver Diseases Treatment Business (2017-2022)
11.5.5 Novartis Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Liver Diseases Treatment Introduction
11.6.4 Pfizer Revenue in Liver Diseases Treatment Business (2017-2022)
11.6.5 Pfizer Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Liver Diseases Treatment Introduction
11.7.4 Roche Revenue in Liver Diseases Treatment Business (2017-2022)
11.7.5 Roche Recent Development
11.8 Sanofi-Aventis
11.8.1 Sanofi-Aventis Company Detail
11.8.2 Sanofi-Aventis Business Overview
11.8.3 Sanofi-Aventis Liver Diseases Treatment Introduction
11.8.4 Sanofi-Aventis Revenue in Liver Diseases Treatment Business (2017-2022)
11.8.5 Sanofi-Aventis Recent Development
11.9 Takeda Pharmaceutical
11.9.1 Takeda Pharmaceutical Company Detail
11.9.2 Takeda Pharmaceutical Business Overview
11.9.3 Takeda Pharmaceutical Liver Diseases Treatment Introduction
11.9.4 Takeda Pharmaceutical Revenue in Liver Diseases Treatment Business (2017-2022)
11.9.5 Takeda Pharmaceutical Recent Development
11.10 Zydus Pharmaceuticals
11.10.1 Zydus Pharmaceuticals Company Detail
11.10.2 Zydus Pharmaceuticals Business Overview
11.10.3 Zydus Pharmaceuticals Liver Diseases Treatment Introduction
11.10.4 Zydus Pharmaceuticals Revenue in Liver Diseases Treatment Business (2017-2022)
11.10.5 Zydus Pharmaceuticals Recent Development
11.11 Glaxosmithkline
11.11.1 Glaxosmithkline Company Detail
11.11.2 Glaxosmithkline Business Overview
11.11.3 Glaxosmithkline Liver Diseases Treatment Introduction
11.11.4 Glaxosmithkline Revenue in Liver Diseases Treatment Business (2017-2022)
11.11.5 Glaxosmithkline Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Detail
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Liver Diseases Treatment Introduction
11.12.4 Bristol-Myers Squibb Revenue in Liver Diseases Treatment Business (2017-2022)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 General Electric
11.13.1 General Electric Company Detail
11.13.2 General Electric Business Overview
11.13.3 General Electric Liver Diseases Treatment Introduction
11.13.4 General Electric Revenue in Liver Diseases Treatment Business (2017-2022)
11.13.5 General Electric Recent Development
11.14 Koninklijke Philips
11.14.1 Koninklijke Philips Company Detail
11.14.2 Koninklijke Philips Business Overview
11.14.3 Koninklijke Philips Liver Diseases Treatment Introduction
11.14.4 Koninklijke Philips Revenue in Liver Diseases Treatment Business (2017-2022)
11.14.5 Koninklijke Philips Recent Development
11.15 Siemens
11.15.1 Siemens Company Detail
11.15.2 Siemens Business Overview
11.15.3 Siemens Liver Diseases Treatment Introduction
11.15.4 Siemens Revenue in Liver Diseases Treatment Business (2017-2022)
11.15.5 Siemens Recent Development
11.16 Canon Medical Systems Corp
11.16.1 Canon Medical Systems Corp Company Detail
11.16.2 Canon Medical Systems Corp Business Overview
11.16.3 Canon Medical Systems Corp Liver Diseases Treatment Introduction
11.16.4 Canon Medical Systems Corp Revenue in Liver Diseases Treatment Business (2017-2022)
11.16.5 Canon Medical Systems Corp Recent Development
11.17 Hitachi
11.17.1 Hitachi Company Detail
11.17.2 Hitachi Business Overview
11.17.3 Hitachi Liver Diseases Treatment Introduction
11.17.4 Hitachi Revenue in Liver Diseases Treatment Business (2017-2022)
11.17.5 Hitachi Recent Development
11.18 Elekta
11.18.1 Elekta Company Detail
11.18.2 Elekta Business Overview
11.18.3 Elekta Liver Diseases Treatment Introduction
11.18.4 Elekta Revenue in Liver Diseases Treatment Business (2017-2022)
11.18.5 Elekta Recent Development
11.19 Neusoft Corporation
11.19.1 Neusoft Corporation Company Detail
11.19.2 Neusoft Corporation Business Overview
11.19.3 Neusoft Corporation Liver Diseases Treatment Introduction
11.19.4 Neusoft Corporation Revenue in Liver Diseases Treatment Business (2017-2022)
11.19.5 Neusoft Corporation Recent Development
11.20 Samsung Healthcare
11.20.1 Samsung Healthcare Company Detail
11.20.2 Samsung Healthcare Business Overview
11.20.3 Samsung Healthcare Liver Diseases Treatment Introduction
11.20.4 Samsung Healthcare Revenue in Liver Diseases Treatment Business (2017-2022)
11.20.5 Samsung Healthcare Recent Development
11.21 BPL Medical Technologies
11.21.1 BPL Medical Technologies Company Detail
11.21.2 BPL Medical Technologies Business Overview
11.21.3 BPL Medical Technologies Liver Diseases Treatment Introduction
11.21.4 BPL Medical Technologies Revenue in Liver Diseases Treatment Business (2017-2022)
11.21.5 BPL Medical Technologies Recent Development
11.22 Cura Healthcare
11.22.1 Cura Healthcare Company Detail
11.22.2 Cura Healthcare Business Overview
11.22.3 Cura Healthcare Liver Diseases Treatment Introduction
11.22.4 Cura Healthcare Revenue in Liver Diseases Treatment Business (2017-2022)
11.22.5 Cura Healthcare Recent Development
11.23 Angion Biomedica
11.23.1 Angion Biomedica Company Detail
11.23.2 Angion Biomedica Business Overview
11.23.3 Angion Biomedica Liver Diseases Treatment Introduction
11.23.4 Angion Biomedica Revenue in Liver Diseases Treatment Business (2017-2022)
11.23.5 Angion Biomedica Recent Development
11.24 Achillion Pharmaceuticals
11.24.1 Achillion Pharmaceuticals Company Detail
11.24.2 Achillion Pharmaceuticals Business Overview
11.24.3 Achillion Pharmaceuticals Liver Diseases Treatment Introduction
11.24.4 Achillion Pharmaceuticals Revenue in Liver Diseases Treatment Business (2017-2022)
11.24.5 Achillion Pharmaceuticals Recent Development
11.25 Gilead Sciences
11.25.1 Gilead Sciences Company Detail
11.25.2 Gilead Sciences Business Overview
11.25.3 Gilead Sciences Liver Diseases Treatment Introduction
11.25.4 Gilead Sciences Revenue in Liver Diseases Treatment Business (2017-2022)
11.25.5 Gilead Sciences Recent Development
11.26 LG Life Sciences
11.26.1 LG Life Sciences Company Detail
11.26.2 LG Life Sciences Business Overview
11.26.3 LG Life Sciences Liver Diseases Treatment Introduction
11.26.4 LG Life Sciences Revenue in Liver Diseases Treatment Business (2017-2022)
11.26.5 LG Life Sciences Recent Development
11.27 Verva Pharmaceuticals
11.27.1 Verva Pharmaceuticals Company Detail
11.27.2 Verva Pharmaceuticals Business Overview
11.27.3 Verva Pharmaceuticals Liver Diseases Treatment Introduction
11.27.4 Verva Pharmaceuticals Revenue in Liver Diseases Treatment Business (2017-2022)
11.27.5 Verva Pharmaceuticals Recent Development
11.28 Shenzhen Kangtai Biological Products
11.28.1 Shenzhen Kangtai Biological Products Company Detail
11.28.2 Shenzhen Kangtai Biological Products Business Overview
11.28.3 Shenzhen Kangtai Biological Products Liver Diseases Treatment Introduction
11.28.4 Shenzhen Kangtai Biological Products Revenue in Liver Diseases Treatment Business (2017-2022)
11.28.5 Shenzhen Kangtai Biological Products Recent Development
11.29 Raptor Pharmaceuticals
11.29.1 Raptor Pharmaceuticals Company Detail
11.29.2 Raptor Pharmaceuticals Business Overview
11.29.3 Raptor Pharmaceuticals Liver Diseases Treatment Introduction
11.29.4 Raptor Pharmaceuticals Revenue in Liver Diseases Treatment Business (2017-2022)
11.29.5 Raptor Pharmaceuticals Recent Development
11.30 ProMetic Life Sciences
11.30.1 ProMetic Life Sciences Company Detail
11.30.2 ProMetic Life Sciences Business Overview
11.30.3 ProMetic Life Sciences Liver Diseases Treatment Introduction
11.30.4 ProMetic Life Sciences Revenue in Liver Diseases Treatment Business (2017-2022)
11.30.5 ProMetic Life Sciences Recent Development
11.31 Phenex Pharmaceuticals
11.31.1 Phenex Pharmaceuticals Company Detail
11.31.2 Phenex Pharmaceuticals Business Overview
11.31.3 Phenex Pharmaceuticals Liver Diseases Treatment Introduction
11.31.4 Phenex Pharmaceuticals Revenue in Liver Diseases Treatment Business (2017-2022)
11.31.5 Phenex Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Liver Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Chemotherapy Drugs
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Anti-Viral Drugs
Table 5. Key Players of Immunoglobulins
Table 6. Key Players of Corticosteroids
Table 7. Key Players of Vaccines
Table 8. Key Players of Anti-Rejection Drugs/Immunosuppressant
Table 9. Global Liver Diseases Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Liver Diseases Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Liver Diseases Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Liver Diseases Treatment Market Share by Region (2017-2022)
Table 13. Global Liver Diseases Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Liver Diseases Treatment Market Share by Region (2023-2028)
Table 15. Liver Diseases Treatment Market Trends
Table 16. Liver Diseases Treatment Market Drivers
Table 17. Liver Diseases Treatment Market Challenges
Table 18. Liver Diseases Treatment Market Restraints
Table 19. Global Liver Diseases Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Liver Diseases Treatment Market Share by Players (2017-2022)
Table 21. Global Top Liver Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Diseases Treatment as of 2021)
Table 22. Ranking of Global Top Liver Diseases Treatment Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Liver Diseases Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Liver Diseases Treatment Product Solution and Service
Table 26. Date of Enter into Liver Diseases Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Liver Diseases Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Liver Diseases Treatment Revenue Market Share by Type (2017-2022)
Table 30. Global Liver Diseases Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Liver Diseases Treatment Revenue Market Share by Type (2023-2028)
Table 32. Global Liver Diseases Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Liver Diseases Treatment Revenue Market Share by Application (2017-2022)
Table 34. Global Liver Diseases Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Liver Diseases Treatment Revenue Market Share by Application (2023-2028)
Table 36. North America Liver Diseases Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Liver Diseases Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Liver Diseases Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 39. Europe Liver Diseases Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 40. Asia-Pacific Liver Diseases Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 41. Asia-Pacific Liver Diseases Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 42. Latin America Liver Diseases Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Latin America Liver Diseases Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Middle East & Africa Liver Diseases Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 45. Middle East & Africa Liver Diseases Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Liver Diseases Treatment Product
Table 49. Abbott Laboratories Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Bayer Schering Company Detail
Table 52. Bayer Schering Business Overview
Table 53. Bayer Schering Liver Diseases Treatment Product
Table 54. Bayer Schering Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 55. Bayer Schering Recent Development
Table 56. Eli Lilly Company Detail
Table 57. Eli Lilly Business Overview
Table 58. Eli Lilly Liver Diseases Treatment Product
Table 59. Eli Lilly Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 60. Eli Lilly Recent Development
Table 61. Merck Company Detail
Table 62. Merck Business Overview
Table 63. Merck Liver Diseases Treatment Product
Table 64. Merck Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Novartis Company Detail
Table 67. Novartis Business Overview
Table 68. Novartis Liver Diseases Treatment Product
Table 69. Novartis Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Pfizer Company Detail
Table 72. Pfizer Business Overview
Table 73. Pfizer Liver Diseases Treatment Product
Table 74. Pfizer Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Roche Company Detail
Table 77. Roche Business Overview
Table 78. Roche Liver Diseases Treatment Product
Table 79. Roche Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 80. Roche Recent Development
Table 81. Sanofi-Aventis Company Detail
Table 82. Sanofi-Aventis Business Overview
Table 83. Sanofi-Aventis Liver Diseases Treatment Product
Table 84. Sanofi-Aventis Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 85. Sanofi-Aventis Recent Development
Table 86. Takeda Pharmaceutical Company Detail
Table 87. Takeda Pharmaceutical Business Overview
Table 88. Takeda Pharmaceutical Liver Diseases Treatment Product
Table 89. Takeda Pharmaceutical Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 90. Takeda Pharmaceutical Recent Development
Table 91. Zydus Pharmaceuticals Company Detail
Table 92. Zydus Pharmaceuticals Business Overview
Table 93. Zydus Pharmaceuticals Liver Diseases Treatment Product
Table 94. Zydus Pharmaceuticals Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 95. Zydus Pharmaceuticals Recent Development
Table 96. Glaxosmithkline Company Detail
Table 97. Glaxosmithkline Business Overview
Table 98. Glaxosmithkline Liver Diseases TreatmentProduct
Table 99. Glaxosmithkline Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 100. Glaxosmithkline Recent Development
Table 101. Bristol-Myers Squibb Company Detail
Table 102. Bristol-Myers Squibb Business Overview
Table 103. Bristol-Myers Squibb Liver Diseases TreatmentProduct
Table 104. Bristol-Myers Squibb Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 105. Bristol-Myers Squibb Recent Development
Table 106. General Electric Company Detail
Table 107. General Electric Business Overview
Table 108. General Electric Liver Diseases TreatmentProduct
Table 109. General Electric Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 110. General Electric Recent Development
Table 111. Koninklijke Philips Company Detail
Table 112. Koninklijke Philips Business Overview
Table 113. Koninklijke Philips Liver Diseases TreatmentProduct
Table 114. Koninklijke Philips Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 115. Koninklijke Philips Recent Development
Table 116. Siemens Company Detail
Table 117. Siemens Business Overview
Table 118. Siemens Liver Diseases TreatmentProduct
Table 119. Siemens Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 120. Siemens Recent Development
Table 121. Canon Medical Systems Corp Company Detail
Table 122. Canon Medical Systems Corp Business Overview
Table 123. Canon Medical Systems Corp Liver Diseases TreatmentProduct
Table 124. Canon Medical Systems Corp Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 125. Canon Medical Systems Corp Recent Development
Table 126. Hitachi Company Detail
Table 127. Hitachi Business Overview
Table 128. Hitachi Liver Diseases TreatmentProduct
Table 129. Hitachi Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 130. Hitachi Recent Development
Table 131. Elekta Company Detail
Table 132. Elekta Business Overview
Table 133. Elekta Liver Diseases TreatmentProduct
Table 134. Elekta Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 135. Elekta Recent Development
Table 136. Neusoft Corporation Company Detail
Table 137. Neusoft Corporation Business Overview
Table 138. Neusoft Corporation Liver Diseases TreatmentProduct
Table 139. Neusoft Corporation Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 140. Neusoft Corporation Recent Development
Table 141. Samsung Healthcare Company Detail
Table 142. Samsung Healthcare Business Overview
Table 143. Samsung Healthcare Liver Diseases TreatmentProduct
Table 144. Samsung Healthcare Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 145. Samsung Healthcare Recent Development
Table 146. BPL Medical Technologies Company Detail
Table 147. BPL Medical Technologies Business Overview
Table 148. BPL Medical Technologies Liver Diseases TreatmentProduct
Table 149. BPL Medical Technologies Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 150. BPL Medical Technologies Recent Development
Table 151. Cura Healthcare Company Detail
Table 152. Cura Healthcare Business Overview
Table 153. Cura Healthcare Liver Diseases TreatmentProduct
Table 154. Cura Healthcare Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 155. Cura Healthcare Recent Development
Table 156. Angion Biomedica Company Detail
Table 157. Angion Biomedica Business Overview
Table 158. Angion Biomedica Liver Diseases TreatmentProduct
Table 159. Angion Biomedica Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 160. Angion Biomedica Recent Development
Table 161. Achillion Pharmaceuticals Company Detail
Table 162. Achillion Pharmaceuticals Business Overview
Table 163. Achillion Pharmaceuticals Liver Diseases TreatmentProduct
Table 164. Achillion Pharmaceuticals Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 165. Achillion Pharmaceuticals Recent Development
Table 166. Gilead Sciences Company Detail
Table 167. Gilead Sciences Business Overview
Table 168. Gilead Sciences Liver Diseases TreatmentProduct
Table 169. Gilead Sciences Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 170. Gilead Sciences Recent Development
Table 171. LG Life Sciences Company Detail
Table 172. LG Life Sciences Business Overview
Table 173. LG Life Sciences Liver Diseases TreatmentProduct
Table 174. LG Life Sciences Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 175. LG Life Sciences Recent Development
Table 176. Verva Pharmaceuticals Company Detail
Table 177. Verva Pharmaceuticals Business Overview
Table 178. Verva Pharmaceuticals Liver Diseases TreatmentProduct
Table 179. Verva Pharmaceuticals Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 180. Verva Pharmaceuticals Recent Development
Table 181. Shenzhen Kangtai Biological Products Company Detail
Table 182. Shenzhen Kangtai Biological Products Business Overview
Table 183. Shenzhen Kangtai Biological Products Liver Diseases TreatmentProduct
Table 184. Shenzhen Kangtai Biological Products Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 185. Shenzhen Kangtai Biological Products Recent Development
Table 186. Raptor Pharmaceuticals Company Detail
Table 187. Raptor Pharmaceuticals Business Overview
Table 188. Raptor Pharmaceuticals Liver Diseases TreatmentProduct
Table 189. Raptor Pharmaceuticals Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 190. Raptor Pharmaceuticals Recent Development
Table 191. ProMetic Life Sciences Company Detail
Table 192. ProMetic Life Sciences Business Overview
Table 193. ProMetic Life Sciences Liver Diseases TreatmentProduct
Table 194. ProMetic Life Sciences Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 195. ProMetic Life Sciences Recent Development
Table 196. Phenex Pharmaceuticals Company Detail
Table 197. Phenex Pharmaceuticals Business Overview
Table 198. Phenex Pharmaceuticals Liver Diseases Treatment Product
Table 199. Phenex Pharmaceuticals Revenue in Liver Diseases Treatment Business (2017-2022) & (US$ Million)
Table 200. Phenex Pharmaceuticals Recent Development
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liver Diseases Treatment Market Share by Type: 2021 VS 2028
Figure 2. Chemotherapy Drugs Features
Figure 3. Targeted Therapy Features
Figure 4. Anti-Viral Drugs Features
Figure 5. Immunoglobulins Features
Figure 6. Corticosteroids Features
Figure 7. Vaccines Features
Figure 8. Anti-Rejection Drugs/Immunosuppressant Features
Figure 9. Global Liver Diseases Treatment Market Share by Application in 2021 & 2028
Figure 10. Cancer Case Studies
Figure 11. Hepatitis Case Studies
Figure 12. Cirrhosis Case Studies
Figure 13. Other Case Studies
Figure 14. Liver Diseases Treatment Report Years Considered
Figure 15. Global Liver Diseases Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Liver Diseases Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Liver Diseases Treatment Market Share by Region: 2021 VS 2028
Figure 18. Global Liver Diseases Treatment Market Share by Players in 2021
Figure 19. Global Top Liver Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Diseases Treatment as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Liver Diseases Treatment Revenue in 2021
Figure 21. North America Liver Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. North America Liver Diseases Treatment Market Share by Country (2017-2028)
Figure 23. United States Liver Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Liver Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Liver Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Liver Diseases Treatment Market Share by Country (2017-2028)
Figure 27. Germany Liver Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Liver Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Liver Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Liver Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Liver Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Liver Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Liver Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Liver Diseases Treatment Market Share by Region (2017-2028)
Figure 35. China Liver Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Liver Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Liver Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Liver Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Liver Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Liver Diseases Treatment Market Size YoY Growth (2017-2
  • Global Microstream Capnography Equipment Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Desktop Type - Portable Type Segment by Application - Critical Care - Emergency Medic......
  • Global Long-Term Therapeutic Bed Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 90
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Mechanical Type - Electric Type Segment by Application - Home - Hospital ......
  • Global Mainstream Capnography Equipment Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 95
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Desktop Type - Portable Type Segment by Application - Critical Care - Emergency Medic......
  • Global Critical Care Therapeutic Bed Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Mechanical Type - Electric Type Segment by Application - Home - Hospital ......
  • Global Manual Wound Irrigation System Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 118
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Disposable - Reusable Segment by Application - Outpatient Surgery Center - Hospital......
  • Global Wrist-worn Pulse Oximeter Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 98
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Separate Sensor - Intergated Sensor Segment by Application - Hospital - Ambulatory Su......
  • Global Medical Wellness Device Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 109
    Medical Wellness Device market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Medical Wellness Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Sphygmomanometer - Diabetes Monitoring Equipment - Pulse Oxime......
  • Global Disposable EEG Electrode Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 89
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Cup Electrode - Patch Electrode - Disk Electrode - Other Segment by Application......
  • Global Leukapheresis Products Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 92
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Leukapheresis Disposables - Apheresis Devices - Leukoreduction Filters Segment by Applicatio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs